Prescription drug · ANDA
Lactulose NDC 83745-405
Lactulose 10 g/15mL · Solution · Oral · APOZEAL PHARMACEUTICALS INC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 83745-405-16 | 83745040516 | 473 mL in 1 BOTTLE (83745-405-16)Marketed from Dec 20, 2024 | |
| 83745-405-32 | 83745040532 | 946 mL in 1 BOTTLE (83745-405-32)Marketed from Dec 20, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Lactulose
- Generic name (nonproprietary)
- lactulose
- Active ingredients
- Lactulose — 10 g/15mL
- Dosage form
- Solution
- Route
- Oral
- Labeler
- APOZEAL PHARMACEUTICALS INC
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 207786
- Marketing start
- Listing expires
- Other FDA classes
- Acidifying Activity (Mechanism)Osmotic Activity (Mechanism)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)
- Identifiers
- Product ID 83745-405_da3c87b0-6781-4c58-83ca-1839cf914333SPL ID da3c87b0-6781-4c58-83ca-1839cf914333SPL set ID 72ac130a-de85-464d-9e9b-05cac0c54db1RxCUI 391937UNII 9U7D5QH5AEUPC 0383745405324, 0383745405164
- Pharmacologic class
- Osmotic Laxative
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N483745040516followed by a unit qualifier and the quantityPackage 83745-0405-16. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE For the treatment of constipation. In patients with a history of chronic constipation, lactulose solution therapy increases the number of bowel movements per day and the number of days on which bowel movements occur.
Excerpt only. Read the full label for complete information.